MiniMed Group Inc. (MMED)
The price, the headline numbers and the latest news, in one place.
MiniMed Group Inc. (MMED) Stock Price, Analysis & Data
| Bid | 14.01 |
| Market Cap | 5.32B |
| Revenue (ttm) | 3.1B |
| Net Income (ttm) | -333M |
| n/a | |
| -1.24 | |
| n/a | |
| 28.88 | |
| P/B (ttm) | 1.47 |
| P/S (ttm) | 1.72 |
| Earnings Date | Sep 1, 2026 |
| Ask | 24.38 |
| Volume | 1,102,408 |
| Avg. Volume (20D) | 1,166,322 |
| Open | 19.95 |
| Previous Close | 19.94 |
| Day's Range | 18.85 - 19.95 |
| 52-Week Range | 10.65 - 20.88 |
| Analyst | Strong Buy |
| Price Target | 20.5 (8.35%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About MMED
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a su...
Financial Performance
In 2026, MiniMed's revenue was 3.1B, an increase of 14.25% compared to the previous year's 2.71B. Earnings were -333M, an increase of 56.34%.
Financial StatementsAnalyst Forecast
According to 12 analyst ratings, the average rating for MMED stock is "Strong Buy". The 12-month stock price forecast is 20.5, which is upside of 8.35% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $837M misses estimates by $0, with Infinity% YoY growth.
- EPS of -0.6 misses estimates by -0.38, with -Infinity% YoY decline.
Analysts project revenue of ... Upgrade
